[1]
|
Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O’Callaghan, C.A., Lasserson, D.S. and Hobbs, F.D. (2016) Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLOS ONE, 11, e0158765. https://doi.org/10.1371/journal.pone.0158765
|
[2]
|
Wang, L., Xu, X., Zhang, M., Hu, C., Zhang, X., Li, C., Nie, S., Huang, Z., Zhao, Z., Hou, F.F. and Zhou, M. (2023) Prevalence of Chronic Kidney Disease in China: Results from the Sixth China Chronic Disease and Risk Factor Surveillance. JAMA Internal Medicine, 183, 298-310. https://doi.org/10.1001/jamainternmed.2022.6817
|
[3]
|
Zhuang, Z., Tong, M., Clarke, R., Wang, B., Huang, T. and Li, L. (2022) Probability of Chronic Kidney Disease and Associated Risk Factors in Chinese Adults: A Cross-Sectional Study of 9 Million Chinese Adults in the Meinian Onehealth Screening Survey. Clinical Kidney Journal, 15, 2228-2236. https://doi.org/10.1093/ckj/sfac176
|
[4]
|
Liprandi, Á.S., Liprandi, M.I.S., Zaidel, E.J., Aisenberg, G.M., Baranchuk, A., Barbosa, E.C.D., Sánchez, G.B., Alexander, B., Zanetti, F.T.L., Santi, R.L., Múnera-Echeverri, A.G., Perel, P., Piskorz, D., Ruiz-Mori, C.E., Saucedo, J., Valdez, O., Juanatey, J.R.G., Piñeiro, D.J., Pinto, F.J. and Quintana, F.S.W. (2021) Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus Document of the Inter-American Society of Cardiology and the Word Heart Federation. Global Heart, 16, 55. https://doi.org/10.5334/gh.1069
|
[5]
|
Johansen, K.L., Chertow, G.M., Foley, R.N., Gilbertson, D.T., Herzog, C.A., Ishani, A., Israni, A.K., Ku, E., Kurella Tamura, M., Li, S., Li, S., Liu, J., Obrador, G.T., O’Hare, A.M., Peng, Y., Powe, N.R., Roetker, N.S., St Peter, W.L., Abbott, K.C., Chan, K.E., Wetmore, J.B., et al. (2021) US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases, 77, A7-A8. https://doi.org/10.1053/j.ajkd.2021.01.002
|
[6]
|
黄燕萍, 陈楠. 慢性肾脏病患者心血管疾病的研究现状[J]. 国际泌尿系统杂志, 2007, 27(2): 234-237.
|
[7]
|
侯凡凡, 马志刚, 梅长林, 等. 中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J]. 中华医学杂志, 2005(7): 458-463.
|
[8]
|
Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., Lameire, N. and European Uremic Toxin Work Group (2005) Chronic Kidney Disease as Cause of Cardiovascular Morbidity and Mortality. Nephrology, Dialysis, Transplantation, 20, 1048-1056. https://doi.org/10.1093/ndt/gfh813
|
[9]
|
Rosenzweig, A. and Seidman, C.E. (1991) Atrial Natriuretic Factor and Related Peptide Hormones. Annual Review of Biochemistry, 60, 229-255. https://doi.org/10.1146/annurev.bi.60.070191.001305
|
[10]
|
Federico, C. (2010) Natriuretic Peptide System and Cardiovascular Disease. Heart Views, 11, 10-15.
|
[11]
|
Nakagawa, O., Ogawa, Y., Itoh, H., Suga, S., Komatsu, Y., Kishimoto, I., Nishino, K., Yoshimasa, T. and Nakao, K. (1995) Rapid Transcriptional Activation and Early MRNA Turnover of Brain Natriuretic Peptide in Cardiocyte Hypertrophy. Evidence for Brain Natriuretic Peptide as an “Emergency” Cardiac Hormone against Ventricular Overload. The Journal of Clinical Investigation, 96, 1280-1287. https://doi.org/10.1172/JCI118162
|
[12]
|
Daniels, L.B. and Maisel, A.S. (2007) Natriuretic Peptides. Journal of the American College of Cardiology, 50, 2357-2368. https://doi.org/10.1016/j.jacc.2007.09.021
|
[13]
|
Miettinen, K.H., Lassus, J., Harjola, V.P., Siirilä-Waris, K., Melin, J., Punnonen, K.R., Nieminen, M.S., Laakso, M. and Peuhkurinen, K.J. (2008) Prognostic Role of Pro-and Anti-Inflammatory Cytokines and Their Polymorphisms in Acute Decompensated Heart Failure. European Journal of Heart Failure, 10, 396-403. https://doi.org/10.1016/j.ejheart.2008.02.008
|
[14]
|
Kottgen, A., Russell, S.D., Loehr, L.R., Crainiceanu, C.M., Rosamond, W.D., Chang, P.P., Chambless, L.E. and Coresh, J. (2007) Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. Journal of the American Society of Nephrology, 18, 1307-1315. https://doi.org/10.1681/ASN.2006101159
|
[15]
|
McMurray, J.J., Petrie, M.C., Murdoch, D.R. and Davie, A.P. (1998) Clinical Epidemiology of Heart Failure: Public and Private Health Burden. European Heart Journal, 19, 9-16.
|
[16]
|
Dokainish, H., Teo, K., Zhu, J., Roy, A., Al-Habib, K., ElSayed, A., Palileo, L., Jaramillo, P.L., Karaye, K., Yusoff, K., Orlandini, A., Sliwa, K., Mondo, C., Lanas, F., Dorairaj, P., Huffman, M., Badr, A., Elmaghawry, M., Damasceno, A., Belley-Cote, E., Yusuf, S., et al. (2015) Heart Failure in Low-and Middle-Income Countries: Background, Rationale, and Design of the INTERnational Congestive Heart Failure Study (INTER-CHF) American Heart Journal, 170, 627-634.e1. https://doi.org/10.1016/j.ahj.2015.07.008
|
[17]
|
Yeboah, J., Rodriguez, C.J., Stacey, B., Lima, J.A., Liu, S., Carr, J.J., Hundley, W.G. and Herrington, D.M. (2012) Prognosis of Individuals with Asymptomatic Left Ventricular Systolic Dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA) Circulation, 126, 2713-2719. https://doi.org/10.1161/CIRCULATIONAHA.112.112201
|
[18]
|
Mujib, M., Zhang, Y., Feller, M.A. and Ahmed, A. (2011) Evidence of a “Heart Failure Belt” in the Southeastern United States. The American Journal of Cardiology, 107, 935-937. https://doi.org/10.1016/j.amjcard.2010.11.012
|
[19]
|
Ziaeian, B. and Fonarow, G.C. (2016) Epidemiology and Aetiology of Heart Failure. Nature Reviews. Cardiology, 13, 368-378. https://doi.org/10.1038/nrcardio.2016.25
|
[20]
|
Takase, H. and Dohi, Y. (2014) Kidney Function Crucially Affects B-Type Natriuretic Peptide (BNP), N-Terminal ProBNP and Their Relationship. European Journal of Clinical Investigation, 44, 303-308. https://doi.org/10.1111/eci.12234
|
[21]
|
Yoshimura, M., Mizuno, Y., Harada, E., Nakayama, M., Shimasaki, Y., Ito, T., Nakamura, S., Soejima, H., Miyamoto, S., Takazoe, K., Ogawa, H., Kugiyama, K., Saito, Y., Nakao, K. and Yasue, H. (2000) Interaction on Metabolic Clearance between A-Type and B-Type Natriuretic Peptides in Patients with Heart Failure. Metabolism: Clinical and Experimental, 49, 1228-1233. https://doi.org/10.1053/meta.2000.8602
|
[22]
|
Bansal, N., Hyre Anderson, A., Yang, W., Christenson, R.H., DeFilippi, C.R., Deo, R., Dries, D.L., Go, A.S., He, J., Kusek, J.W., Lash, J.P., Raj, D., Rosas, S., Wolf, M., Zhang, X., Shlipak, M.G. and Feldman, H.I. (2015) High-Sensitivity Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP) and Risk of Incident Heart Failure in Patients with CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology, 26, 946-956. https://doi.org/10.1681/ASN.2014010108
|
[23]
|
Januzzi Jr., J.L., Camargo, C.A., Anwaruddin, S., Baggish, A.L., Chen, A.A., Krauser, D.G., Tung, R., Cameron, R., Nagurney, J.T., Chae, C.U., Lloyd-Jones, D.M., Brown, D.F., Foran-Melanson, S., Sluss, P.M., Lee-Lewandrowski, E. and Lewandrowski, K.B. (2005) The N-Terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. The American Journal of Cardiology, 95, 948-954. https://doi.org/10.1016/j.amjcard.2004.12.032
|
[24]
|
Fu, S., Luo, L., Ye, P., Yi, S., Liu, Y., Zhu, B., Wang, L., Xiao, T. and Bai, Y. (2013) The Ability of NT-ProBNP to Detect Chronic Heart Failure and Predict All-Cause Mortality Is Higher in Elderly Chinese Coronary Artery Disease Patients with Chronic Kidney Disease. Clinical Interventions in Aging, 8, 409-417. https://doi.org/10.2147/CIA.S42700
|
[25]
|
Wang, S., Li, M., Wang, X., Luo, J., Zou, Y., Hu, Y., Liu, X., Ao, H., Yao, X., Li, C. and Yang, T. (2021) The Ratio of NT-ProBNP to CysC1.53 Predicts Heart Failure in Patients with Chronic Kidney Disease. Frontiers in Cardiovascular Medicine, 8, Article 731864. https://doi.org/10.3389/fcvm.2021.731864
|
[26]
|
Horii, M., Matsumoto, T., Uemura, S., Sugawara, Y., Takitsume, A., Ueda, T., Nakagawa, H., Nishida, T., Soeda, T., Okayama, S., Somekawa, S., Ishigami, K., Takeda, Y., Kawata, H., Kawakami, R. and Saito, Y. (2013) Prognostic Value of B-Type Natriuretic Peptide and Its Amino-Terminal ProBNP Fragment for Cardiovascular Events with Stratification By Renal Function. Journal of Cardiology, 61, 410-416. https://doi.org/10.1016/j.jjcc.2013.01.015
|
[27]
|
Yamada, S., Ishii, H., Takahashi, H., Aoyama, T., Morita, Y., Kasuga, H., Kimura, K., Ito, Y., Takahashi, R., Toriyama, T., Yasuda, Y., Hayashi, M., Kamiya, H., Yuzawa, Y., Maruyama, S., Matsuo, S., Matsubara, T. and Murohara, T. (2010) Prognostic Value of Reduced Left Ventricular Ejection Fraction at Start of Hemodialysis Therapy on Cardiovascular and All-Cause Mortality in End-Stage Renal Disease Patients. Clinical Journal of the American Society of Nephrology, 5, 1793-1798. https://doi.org/10.2215/CJN.00050110
|
[28]
|
鲁凤瑾, 李馨, 李萌, 等. 超声心动图联合血清高敏C反应蛋白及N末端B型钠尿肽前体水平评估冠心病心衰患者心功能的价值研究[J]. 中国医学装备, 2024, 21(2): 84-88, 93.
|
[29]
|
DeFilippi, C.R., Fink, J.C., Nass, C.M., Chen, H. and Christenson, R. (2005) N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Coronary Disease and Left Ventricular Hypertrophy in Asymptomatic CKD Not Requiring Dialysis. American Journal of Kidney Diseases, 46, 35-44. https://doi.org/10.1053/j.ajkd.2005.04.007
|
[30]
|
Untersteller, K., Girerd, N., Duarte, K., Rogacev, K.S., Seiler-Mussler, S., Fliser, D., Rossignol, P. and Heine, G.H. (2016) NT-ProBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4. Clinical Journal of the American Society of Nephrology, 11, 1978-1988. https://doi.org/10.2215/CJN.01660216
|
[31]
|
林琳, 林雪萍, 沈波, 等. 非透析慢性肾脏病患者SST2、NT-ProBNP、Hs-CTnT与左心室构型的相关性[J]. 中国临床医学, 2023, 30(6): 919-926.
|
[32]
|
Mishra, R.K., Li, Y., Ricardo, A.C., Yang, W., Keane, M., Cuevas, M., Christenson, R., DeFilippi, C., Chen, J., He, J., Kallem, R.R., Raj, D.S., Schelling, J.R., Wright, J., Go, A.S., Shlipak, M.G. and Chronic Renal Insufficiency Cohort Investigators (2013) Association of N-Terminal Pro-B-Type Natriuretic Peptide with Left Ventricular Structure and Function in Chronic Kidney Disease (From the Chronic Renal Insufficiency Cohort [CRIC]). The American Journal of Cardiology, 111, 432-438. https://doi.org/10.1016/j.amjcard.2012.10.019
|
[33]
|
Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Kittner, S.J., Lackland, D.T. and American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2014) Heart Disease and Stroke Statistics—2014 Update: A Report from the American Heart Association. Circulation, 129, e28-e292. https://doi.org/10.1161/01.cir.0000441139.02102.80
|
[34]
|
Lamprea-Montealegre, J.A., Zelnick, L.R., Shlipak, M.G., Floyd, J.S., Anderson, A.H., He, J., Christenson, R., Seliger, S.L., Soliman, E.Z., Deo, R., Ky, B., Feldman, H.I., Kusek, J.W., DeFilippi, C.R., Wolf, M.S., Shafi, T., Go, A.S., Bansal, N. and CRIC Study Investigators (2019) Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association, 8, e012200. https://doi.org/10.1161/JAHA.119.012200
|
[35]
|
Tirmenstajn-Jankovic, B., Dimkovic, N., Perunicic-Pekovic, G., Radojicic, Z., Bastac, D., Zikic, S. and Zivanovic, M. (2013) Anemia Is Independently Associated with NT-ProBNP Levels in Asymptomatic Predialysis Patients with Chronic Kidney Disease. Hippokratia, 17, 307-312.
|
[36]
|
Ducros, J., Larifla, L., Merault, H., Galantine, V., Bassien-Capsa, V. and Foucan, L. (2020) N-Terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis. International Journal of Nephrology, 2020, Article ID: 9528014. https://doi.org/10.1155/2020/9528014
|
[37]
|
Bednarek-Skublewska, A., Zaluska, W. and Ksiazek, A. (2010) The Relationship between Serum Level of N-Terminal Pro-B-Type Natriuretic Peptide and Nutritional Status, and Inflammation in Chronic Hemodialysis Patients. Clinical Nephrology, 73, 14-20. https://doi.org/10.5414/CNP73014
|
[38]
|
Lee, Y.J., Song, B.G., Kim, M.S., Cho, S., Chun, W.J., Oh, J.H. and Kim, S.R. (2013) Interaction of Malnutrition, N-Terminal Pro-B-Type Natriuretic Peptide and Ventricular Remodeling in Patients on Maintenance Hemodialysis. Clinical Nephrology, 79, 253-260. https://doi.org/10.5414/CN107684
|
[39]
|
Schwermer, K., Hoppe, K., Radziszewska, D., Kłysz, P., Sawatiuk, P., Nealis, J., Kałużna, M., Kaczmarek, J., Baum, E., Lindholm, B., Pawlaczyk, K. and Oko, A. (2015) N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Hypervolemia and Predictor of Increased Mortality in Patients on Hemodialysis. Polskie Archiwum Medycyny Wewnetrznej, 125, 560-569. https://doi.org/10.20452/pamw.2969
|
[40]
|
Bansal, N., Katz, R., Dalrymple, L., De Boer, I., DeFilippi, C., Kestenbaum, B., Park, M., Sarnak, M., Seliger, S. and Shlipak, M. (2015) NT-ProBNP and Troponin T and Risk of Rapid Kidney Function Decline and Incident CKD in Elderly Adults. Clinical Journal of the American Society of Nephrology, 10, 205-214. https://doi.org/10.2215/CJN.04910514
|
[41]
|
Bruch, C., Reinecke, H., Stypmann, J., Rothenburger, M., Schmid, C., Breithardt, G., Wichter, T. and Gradaus, R. (2006) N-Terminal Pro-Brain Natriuretic Peptide, Kidney Disease and Outcome in Patients with Chronic Heart Failure. The Journal of Heart and Lung Transplantation, 25, 1135-1141. https://doi.org/10.1016/j.healun.2006.05.006
|
[42]
|
马洪珍, 周军, 高飞, 等. NT-ProBNP联合可溶性ST2蛋白对老年慢性肾脏病合并心力衰竭病人的诊断价值[J]. 实用老年医学, 2023, 37(5): 459-463, 469.
|
[43]
|
Palmer, S.C., Yandle, T.G., Frampton, C.M., Troughton, R.W., Nicholls, M.G. and Richards, A.M. (2009) Renal and Cardiac Function for Long-Term (10 Year) Risk Stratification after Myocardial Infarction. European Heart Journal, 30, 1486-1494. https://doi.org/10.1093/eurheartj/ehp132
|
[44]
|
Wang, K., Zelnick, L.R., Anderson, A., Cohen, J., Dobre, M., Deo, R., Feldman, H., Go, A., Hsu, J., Jaar, B., Kansal, M., Shlipak, M., Soliman, E., Rao, P., Weir, M., Bansal, N. and CRIC Study Investigators (2020) Cardiac Biomarkers and Risk of Mortality in CKD (The CRIC Study). Kidney International Reports, 5, 2002-2012. https://doi.org/10.1016/j.ekir.2020.08.028
|
[45]
|
Gromadziński, L., Januszko-Giergielewicz, B., Czarnacka, K. and Pruszczyk, P. (2019) NT-ProBNP in the Prognosis of Death or Need for Renal Replacement Therapy in Patients with Stage 3-5 Chronic Kidney Disease. Cardiorenal Medicine, 9, 125-134. https://doi.org/10.1159/000496238
|
[46]
|
Şimşek, M.A., Değertekin, M., TürerCabbar, A., Hünük, B., Aktürk, S., Erdoğmuş, S., Mutlu, B. and Kozan, Ö. (2020) NT-ProBNP Level in Stage 3-4 Chronic Kidney Disease and Mortality in Long-Term Follow-Up: HAPPY Study Subgroup Analysis. Archives of the Turkish Society of Cardiology, 48, 454-460. https://doi.org/10.5543/tkda.2020.57746
|
[47]
|
Fu, S., Luo, L., Ye, P., Yi, S., Liu, Y., Zhu, B., Wang, L., Xiao, T. and Bai, Y. (2013) The Ability of NT-ProBNP to Detect Chronic Heart Failure and Predict All-Cause Mortality Is Higher in Elderly Chinese Coronary Artery Disease Patients with Chronic Kidney Disease. Clinical Interventions in Aging, 8, 409-417. https://doi.org/10.2147/CIA.S42700
|
[48]
|
Tang, W., Zhang, Y., Wang, Z., Yuan, X., Chen, X., Yang, X., Qi, Z., Zhang, J., Li, J. and Xie, X. (2023) Development and Validation of a Multivariate Model for Predicting Heart Failure Hospitalization and Mortality in Patients Receiving Maintenance Hemodialysis. Renal Failure, 45, 2255686. https://doi.org/10.1080/0886022X.2023.2255686
|
[49]
|
David, S., Kümpers, P., Seidler, V., Biertz, F., Haller, H. and Fliser, D. (2008) Diagnostic Value of N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP) for Left Ventricular Dysfunction in Patients with Chronic Kidney Disease Stage 5 on Haemodialysis. Nephrology, Dialysis, Transplantation, 23, 1370-1377. https://doi.org/10.1093/ndt/gfm700
|
[50]
|
Voroneanu, L., Siriopol, D., Nistor, I., Apetrii, M., Hogas, S., Onofriescu, M. and Covic, A. (2014) Superior Predictive Value for NTproBNP Compared with High Sensitivity CTnT in Dialysis Patients: A Pilot Prospective Observational Study. Kidney & Blood Pressure Research, 39, 636-647. https://doi.org/10.1159/000368452
|
[51]
|
Yeung, S.M.H., Van Londen, M., Nakshbandi, U., Said, M.Y., Eisenga, M.F., Hepkema, B.G., Nolte, I.M., Berger, S.P., De Borst, M.H. and Bakker, S.J.L. (2020) Pretransplant NT-ProBNP, Dialysis Vintage, and Posttransplant Mortality in Kidney Transplant Recipients. Transplantation, 104, 2158-2165. https://doi.org/10.1097/TP.0000000000003125
|
[52]
|
Oterdoom, L.H., De Vries, A.P., Van Ree, R.M., Gansevoort, R.T., Van Son, W.J., Van Der Heide, J.J., Navis, G., De Jong, P.E., Gans, R.O. and Bakker, S.J. (2009) N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant Recipients Versus the General Population. Transplantation, 87, 1562-1570. https://doi.org/10.1097/TP.0b013e3181a4bb80
|
[53]
|
Matsushita, K., Sang, Y., Ballew, S.H., Astor, B.C., Hoogeveen, R.C., Solomon, S.D., Ballantyne, C.M., Woodward, M. and Coresh, J. (2014) Cardiac and Kidney Markers for Cardiovascular Prediction in Individuals with Chronic Kidney Disease: The Atherosclerosis Risk in Communities Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1770-1777. https://doi.org/10.1161/ATVBAHA.114.303465
|